Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 589647Generated: October 31, 2026

2,6-Lutidine → N-methoxycarbonyl ethoxycarboimidoylbiphenyl benzimidazole

https://huagongshe.com/reaction/589647

Reaction equation

Participants

RoleNameHCIDCharge
Reactant2,6-LutidineHCID 7937—
ReactantEthyl chloroformateHCID 10928—
ReactantEthoxycarboimidoyl biphenyl benzimidazoleHCID 86703397—
ReactantHCID 178467363HCID 178467363—
ProductN-methoxycarbonyl ethoxycarboimidoylbiphenyl benzimidazoleHCID 68281542—

Reaction Steps

According to another method disclosed in U.S. '054 for the preparation of azilsartan (Scheme 2), ethoxycarboimidoyl biphenyl benzimidazole derivative of compound of formula (6) reacts with ethylchloroformate in presence of 2,6-dimethylpyridine as base gives N-methoxycarbonyl ethoxycarboimidoylbiphenyl benzimidazole derivative of compound of formula (7). The resulting N-methoxycarbonyl ethoxycarboimidoyl biphenyl benzimidazole compound of formula (7) can be converted to 1,2,4-oxadiazol derivative compound of formula (4) by either of the two ways: (i) by treating the compound of formula (7) with hydroxylamine hydrochloride in presence of sodium methoxide; (ii) by reacting compound of formula (7) with methyl chloroformate in presence of 2,4,6-trimethylpyridine to obtain a residue, which on further addition to a mixture of hydroxylamine hydrochloride and sodium methoxide under reflux yielded compound of formula (4). 1,2,4-Oxadiazol derivative compound of formula (4) thus obtained is further hydrolyzed in presence of a base to obtain azilsartan (5).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09233955B2
Source datasetuspto-grants-2016_01
ORD IDord-2b23953323634ccd9e52768dcd0cf107
Source noteuspto-grants-2016_01